Fecal carriage of carbapenem-resistant Enterobacteriaceae and risk factor analysis in hospitalised patients: A single centre study from India

Indian Journal of Medical Microbiology

Volumn 35, Issue 4, 2017, Pages 555-562

  Mohan, Balvinder ^a   Prasad, Amber ^b   Kaur, Harsimran ^a   Hallur, Vinaykumar ^c   Gautam, Neha ^d   Taneja, Neelam ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b REGIONAL INSTITUTE OF MEDICAL SCIENCES   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^d Dr Yashwant Singh Parmar Government Medical College   (India)

Author keywords

Carbapenem resistant Enterobacteriaceae; faecal carriage; India

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; CEPHALOSPORIN; IMIPENEM; MEROPENEM; VANCOMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CONTROLLED STUDY; ESCHERICHIA COLI; FECES ANALYSIS; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; RISK FACTOR; BETA-LACTAM RESISTANCE; ENTEROBACTERIACEAE INFECTION; FECES; HETEROZYGOTE; HOSPITALIZATION; INDIA; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDY; TERTIARY CARE CENTER; YOUNG ADULT;

ADOLESCENT; ADULT; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAM RESISTANCE; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; CARRIER STATE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HOSPITALIZATION; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 85041678124     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/ijmm.IJMM_17_144     Document Type: Article

References (36)

1. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028-33.
2. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009;30:1180-5.
3. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, Skoutelis A, et al. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009;53:1868-73.
4. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York city: A new threat to our antibiotic armamentarium. Arch Intern Med 2005;165:1430-5.
5. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:1099-106.
6. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991;35:147-51.
7. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-61.
8. Bush K. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol 2010;13:558-64.
9. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602.
10. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: An evolving crisis of global dimensions. Clin Microbiol Rev 2012;25:682-707.
11. Zhao ZC, Xu XH, Liu MB, Wu J, Lin J, Li B, et al. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital. Am J Infect Control 2014;42:e61-4.
12. Day KM, Ali S, Mirza IA, Sidjabat HE, Silvey A, Lanyon CV, et al. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagn Microbiol Infect Dis 2013;75:187-91.
13. Pantel A, Marchandin H, Prère MF, Boutet-Dubois A, Brieu-Roche N, Gaschet A, et al. Faecal carriage of carbapenemase-producing gram-negative bacilli in hospital settings in Southern France. Eur J Clin Microbiol Infect Dis 2015;34:899-904.
14. Rai S, Das D, Niranjan DK, Singh NP, Kaur IR. Carriage prevalence of carbapenem-resistant Enterobacteriaceae in stool samples: A surveillance study. Australas Med J 2014;7:64-7.
15. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci 2006;1:9-14.
16. Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, Leal-Vega F, Cruz-Hervert LP, García-García L, et al. Factors associated to prevalence and incidence of carbapenem-resistant Enterobacteriaceae fecal carriage: A Cohort study in a Mexican tertiary care hospital. PLoS One 2015;10:e0139883.
17. CDC. FAQs about Choosing and Implementing a CRE Definition; 2015. Available from: http://www.cdc.gov/hai/organisms/cre/definition.html.
18. Réglier-Poupet H, Naas T, Carrer A, Cady A, Adam JM, Fortineau N, et al. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum beta-lactamases. J Med Microbiol 2008;57:310-5.
19. Carrër A, Fortineau N, Nordmann P. Use of chromID extended-spectrum beta-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 2010;48:1913-4.
20. Collee JG, Miles RS, Watt B. Tests for the indentification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie & MacCartney Practical Medical Microbiology. Edinburgh: Churchill Livingstone; 1996. p. 131-49.
21. Chandra BK, Singh G, Taneja N, Pahil S, Singhi S, Sharma M, et al. Diarrhoeagenic Escherichia coli as a predominant cause of paediatric nosocomial diarrhoea in India. J Med Microbiol 2012;61:830-6.
22. CLSI. Performance Standards for Antimicrobial Susceptibility Testing: Twenty First Informational Supplement M100-S21. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2011.
23. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18:268-81.
24. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010;65:490-5.
25. Mulvey MR, Grant JM, Plewes K, Roscoe D, Boyd DA. New delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 2011;17:103-6.
26. Xu Y, Gu B, Huang M, Liu H, Xu T, Xia W, et al. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia. J Thorac Dis 2015;7:376-85.
27. Carlet J. The gut is the epicentre of antibiotic resistance. Antimicrob Resist Infect Control 2012;1:39.
28. Cunha CB, Kassakian SZ, Chan R, Tenover FC, Ziakas P, Chapin KC, et al. Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors. Am J Infect Control 2016;44:126-30.
29. Girlich D, Bouihat N, Poirel L, Benouda A, Nordmann P. High rate of faecal carriage of extended-spectrum β-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin Microbiol Infect 2014;20:350-4.
30. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-8.
31. Perry JD, Naqvi SH, Mirza IA, Alizai SA, Hussain A, Ghirardi S, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 2011;66:2288-94.
32. Kwak YG, Choi SH, Choo EJ, Chung JW, Jeong JY, Kim NJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005;11:165-9.
33. Schechner V, Kotlovsky T, Tarabeia J, Kazma M, Schwartz D, Navon-Venezia S, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011;32:497-503.
34. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and Intensive Care Unit admission. Emerg Infect Dis 2007;13:1144-9.
35. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002;34:340-5.
36. Marchaim D, Chopra T, Bhargava A, Bogan C, Dhar S, Hayakawa K, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: The role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817-30.